# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-02-20T10:42:52.636321
**Route:** OpenRouter + LaTeX
**Tokens:** 14635 in / 1046 out
**Response SHA256:** 2649d50ab6304f0e

---

No fatal errors found in the four required categories.

### 1) DATA–DESIGN ALIGNMENT (CRITICAL)
- **Treatment timing vs. data coverage:** Treated effective dates span **2020–2023** (Table `tab:adoption`), and the claims data cover **Jan 2018–Dec 2024** (Data section; Table `tab:twfe` notes Q1 2018–Q4 2024). This is aligned (max treatment year 2023 ≤ max data year 2024).
- **Post-treatment observations:** Latest adopter is **Nebraska (Jan 1, 2023)** → there are post-treatment quarters through **Q4 2024** (≈8 quarters). Earliest adopter **Georgia (Jan 2020)** has substantial post period. So the DiD design has post-treatment support for all cohorts.
- **Treatment definition consistency:** Treatment is defined as “quarter when permanent Medicaid parity law became effective” and the adoption table provides effective dates consistent with that definition. No contradictory “first-treated year” definitions detected across sections/tables.

### 2) REGRESSION SANITY (CRITICAL)
Checked the regression table(s) with numeric outputs:
- **Table `tab:twfe`**: coefficients and SEs are in plausible ranges for log outcomes (no huge magnitudes; no SEs that are orders of magnitude larger than coefficients).
- **R² values** in Table `tab:twfe` are between 0 and 1.
- No negative SEs, no NA/NaN/Inf values shown, no impossible values.

### 3) COMPLETENESS (CRITICAL)
- No placeholders like **TBD/TODO/XXX/NA** in tables where estimates should be (the “N/A” execution-time macro is in the author footnote, not a results placeholder).
- Regression table reports **Observations** and **standard errors**.
- References to key table/figures appear to correspond to objects present in the source (e.g., `tab:adoption`, `tab:twfe`, `tab:cs_att`, listed figures).

### 4) INTERNAL CONSISTENCY (CRITICAL)
- Sample periods are consistent where they need to be: summary stats are explicitly **state-month** (N=4,284), while regressions are **state-quarter** (N=1,428), and the paper clearly distinguishes these.
- Treated/control counts are consistent: **26 treated + 25 never-treated = 51 units** (50 states + DC).

ADVISOR VERDICT: PASS